Barco has received FDA 510(k) pre-market clearance for its latest version of its VOXAR 3D advanced visualization suite that reportedly further enhances the digital imaging workflow with its seamless integration into PACS, which allows radiologists to increase their efficiency and report studies faster.
The new VOXAR 3D suite comes with a full set of integrated clinical applications, including VOXAR 3D COLONMETRIX for CT colonography and VOXAR 3D PET-CT FUSION for the interpretation of whole body FDG oncology studies.
VOXAR 3D COLONMETRIX provides users with powerful, GPU-accelerated automatic centerline finding, making it possible for radiologists and gastroenterologists to fly through prone and supine colon images smoothly and rapidly. An integrated gravity function keeps the camera position aligned with the scanner table to facilitate spatial understanding as one studies the colon. This full set of powerful, automated features allows radiologists to interpret a colon study and generate a report typically within 10 minutes.
VOXAR 3D PET/CT FUSION is a new clinical application that supports the effective interpretation of whole body FDG oncology studies and allows real-time interaction with PET/CT images. It reportedly enables radiologists to accurately and efficiently blend PET and CT studies to combine anatomical and functional images for rapid lesion analysis and characterization.
February 01, 2024 
